zzlangerhans’ Activity

Wed Sep 24

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for RGDO. 7:53 PM

Up to 30K shares now cost basis 1.71.

Sun Sep 21

CAPS Outperform Pitch

zzlangerhans wrote about Regado BioSciences, Inc. (RGDO) . 2:59 AM

RGDO Outperform

Quite often after profiting on a trade where the favorable outcome had seemed almost inevitable, I ask myself why I hadn't gone bigger and doubled or tripled my profits.The answer, of course, is the existence of stocks like Regado which appear on the [more]

Sat Sep 20

CAPS Outperform Pitch

zzlangerhans wrote about MannKind Corp (MNKD) . 2:52 AM

MNKD Outperform

It's a little sad that the five year price chart on YahooFinance doesn't take me back all the way to when I started covering Mannkind. I always thought I'd be a stock market billionaire before I got to this point. Perhaps I'm not because I never put [more]

Wed Sep 17

CAPS Underperform Pitch

zzlangerhans wrote about AVANIR PHARMACEUTICALS (AVNR) . 9:16 AM

AVNR Underperform

Avanir's share price doubled on Monday morning after the pre-market announcement of positive topline results from a placebo-controlled phase II trial of Nuedexta (AVP-923) for Alzheimer's agitation. I red thumbed it reflexively when the stock seemed [more]

Tue Sep 16

Caps Pick

zzlangerhans made a pick in CAPS. 1:35 PM

Regado BioSciences, Inc. (RGDO) will Outperform the S&P 500

CAPS Outperform Pitch

zzlangerhans wrote about AKEBIA THERAPEUTICS INC COM USD0.00001 (AKBA) . 11:22 AM

AKBA Outperform

I recently added Akebia to my database but it's rather difficult to find anything to get excited about. The platform is based on stimulation of the hypoxia-inducible factor pathway through small molecule inhibitors of HIF prolyl hydroxylase, the [more]

Mon Sep 15

Caps Pick

zzlangerhans made a pick in CAPS. 12:43 PM

AKEBIA THERAPEUTICS INC COM USD0.00001 (AKBA) will Outperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 10:14 AM

AVANIR PHARMACEUTICALS (AVNR) will Underperform the S&P 500

Fri Sep 12

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for AMRN. 2:45 PM

Already out at 1.46 for a profit of $300. Couldn't resist the urge to take some profits on this trader killer.

CAPS Outperform Pitch

zzlangerhans wrote about Amarin Corp plc (ADR) (AMRN) . 10:37 AM

AMRN Outperform

The "revocation of the revocation" trade in Amarin never made much sense to me. The FDA revoked the ANCHOR SPA for a clear reason - to allow a more orderly rejection of Vascepa for the ANCHOR indication, with a reduced risk of legal [more]

Caps Pick

zzlangerhans made a pick in CAPS. 9:35 AM

Amarin Corp plc (ADR) (AMRN) will Outperform the S&P 500

Wed Sep 10

CAPS Underperform Pitch Reply

zzlangerhans commented on TMFBiologyFool's pitch for ARNA. 10:00 PM

The 3 word pitch wins. The Doctor lost the patient.

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for MNOV. 3:09 PM

And sold at 2.82 six months later for profit of $3150. Who knows - this could be the next POS to be a ten bagger but I hate holding winning positions I don't like just on the basis of momentum.

Tue Sep 9

CAPS Underperform Pitch

zzlangerhans wrote about Chimerix (CMRX) . 6:50 PM

CMRX Underperform

Chimerix is ripping of late and I smell a rat. The stock was ailing in May even after the company solved their compassionate use PR nightmare, and management found the exact bottom of the stock to price a huge dilutive financing of 112M. Since then [more]

Caps Pick

zzlangerhans made a pick in CAPS. 2:59 PM

MannKind Corp (MNKD) will Outperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 10:27 AM

Chimerix (CMRX) will Underperform the S&P 500

Mon Sep 8

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for KERX. 2:29 PM

Covered at 15.19 for $880 profit in six hours (market time). Still in proof of concept mode when it comes to shorting.

Sat Sep 6

CAPS Underperform Pitch

zzlangerhans wrote about Keryx Biopharmaceuticals (KERX) . 7:33 PM

KERX Underperform

The period immediately after FDA approval of a company's sole pipeline product is fraught with risk. Momentum traders and speculators will often head for the sidelines, as it is difficult to predict the commercial potential of many newly-approved [more]

Fri Sep 5

Caps Pick

zzlangerhans made a pick in CAPS. 2:17 PM

Keryx Biopharmaceuticals (KERX) will Underperform the S&P 500

Tue Sep 2

CAPS Underperform Pitch

zzlangerhans wrote about Coronado Biosciences, Inc. (CNDO) . 9:50 PM

CNDO Underperform

I hadn't looked at Coronado for a while but I was running my CAPS list and noticed my green thumb had a winning score. I decided to take a quick peek to figure out if I should harvest the gain or let it run. The first thing I noticed was that the [more]

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.83
Player Rank 132 out of 75039
Score 6768.83
Score Change Today -0.81
Accuracy 82.07%
Active Picks 160
Total Picks 1944
Best Pick MDVN (+1157.99)
Worst Pick PCYC (-2886.09)
Average Score per Pick 3.48
Charms Earned 15
Highest Rated Favorite usubanas
Go to zzlangerhans’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show zzlangerhans’ 10 Latest Posts